The notion of 'autoinflammatory' disease was introduced at the end of the 1990s, and, since then, this concept has rapidly evolved. As a result, multiple definitions of autoinflammatory disease, and classifications of conditions encompassed by these definitions, have been proposed; this succession highlights advances that have been made in understanding of the innate immune system, and especially the roles of IL-1β and the inflammasome in autoinflammtory conditions. However, the definitions and classifications that have been suggested to date face a number of structure and content issues. We therefore propose another, more clinically-oriented, definition: autoinflammatory diseases are diseases with clinical signs of inflammation, associated with elevated levels of acute-phase reactants, which are attributable to dysfunction of the innate immune system, genetically-determined or triggered by an endogenous factor. From this foundation, we propose a clinically-based classification of autoinflammatory diseases, and go on to discuss how immunological diseases as a whole, including autoimmune diseases, can be appropriately located within a continuum only if the classification process is multidimensional. For this purpose, we appeal to the philosophical concepts of family resemblance and signature.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Orphanet Journal of Rare Diseases Open Access 17 July 2023
Nature Communications Open Access 28 August 2019
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
McDermott, M. F. et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133–144 (1999).
French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25–31 (1997).
International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797–807 (1997).
McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome. Nat. Genet. 29, 301–305 (2001).
Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417–426 (2002).
Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 20, 319–325 (2004).
Hawkins, P. N., Lachmann, H. J. & McDermott, M. F. Interleukin-1-receptor antagonist in the Muckle–Wells syndrome. N. Engl. J. Med. 348, 2583–2584 (2003).
Dinarello, C. A. Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1β secretion and disease activity. Arthritis Rheum. 56, 2817–2822 (2007).
de Koning, H. D., Schalkwijk, J., van der Meer, J. W. & Simon, A. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. J. Allergy Clin. Immunol. 128, 1352–1354 (2011).
Krause, K., Feist, E., Fiene, M., Kallinich, T. & Maurer, M. Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. J. Allergy Clin. Immunol. 129, 848–850 (2012).
Arima, K. et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo–Nishimura syndrome. Proc. Natl Acad. Sci. USA 108, 14914–14919 (2011).
Dinarello, C. A. Blocking interleukin-1β in acute and chronic autoinflammatory diseases. J. Intern. Med. 269, 16–28 (2011).
Murphy, E. A. The Logic of Medicine. 122–126 (Johns Hopkins University Press, Baltimore, 1976).
Masters, S. L., Simon, A., Aksentijevich, I. & Kastner, D. L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621–668 (2009).
Kastner, D. L., Aksentijevich, I. & Goldbach-Mansky, R. Autoinflammatory disease reloaded: a clinical perspective. Cell 140, 784–790 (2010).
Wittgenstein, L. Philosophical investigations (Blackwell, Oxford, 1953).
Verbsky, J. W. Monogenic causes of inflammatory disease in rheumatology. Curr. Opin. Rheumatol. 24, 506–514 (2012).
Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178–1186 (2012).
Ombrello, M. J. et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 366, 330–338 (2012).
Lachmann, H. J. et al. Natural history and outcome in systemic AA amyloidosis. N. Engl. J. Med. 356, 2361–2371 (2007).
Foucault, M. Les Mots et les Choses 17–29 (Gallimard, Paris, 1966).
Feramisco, J. D., Sadreyev, R. I., Murray, M. L., Grishin, N. V. & Tsao, H. Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. J. Invest. Dermatol. 129, 2628–2636 (2009).
Samarghitean, C., Ortutay, C. & Vihinen, M. Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters. J. Immunol. 183, 7569–7575 (2009).
The authors declare no competing financial interests.
Proposed categories of autoinflammatory diseases from selected classifications (PDF 94 kb)
Classification of autoinflammatory diseases according to their main pathological features* (DOC 41 kb)
The immune disease continuum. Schematic representation of the continuum of inflammatory diseases proposed by McGonagle and McDermott.4 (PDF 149 kb)
The continuum of immune diseases along the gradient of amyloidosis prevalence. (PDF 130 kb)
About this article
Cite this article
Grateau, G., Hentgen, V., Stojanovic, K. et al. How should we approach classification of autoinflammatory diseases?. Nat Rev Rheumatol 9, 624–629 (2013). https://doi.org/10.1038/nrrheum.2013.101
This article is cited by
Orphanet Journal of Rare Diseases (2023)
Nature Reviews Rheumatology (2021)
Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort
Clinical Rheumatology (2021)
Nature Reviews Rheumatology (2020)
Nature Communications (2019)